Dr. Beer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Z Lens LLC
591 22nd Ave SE
Saint Petersburg, FL 33705Phone+1 518-573-6528
Summary
- Dr. Beer is the inventor of Zonular Capture Haptics (ZCH) technology platform and the Founder & CEO of Z Lens LLC. Z lens LLC has manufactured the only Accommodating-Disaccommodating Intraocular Lens (AD-IOL) that has captured the entire movement of the young, natural, crystalline lens. The AD-IOL's are being tested in the best animal model of accommodation by a top academic, independent research team. Based on preclinical results, the AD-IOL would meet FDA guidelines for an accommodating IOL.
Dr. Beer is a nationally known researcher and retinal surgeon with over 25 years of experience. He retired from his clinical retina practice November 2015 to dedicate his full energy to Z Lens LLC.
He is a Professor of Ophthalmology at Albany Medical Center, has received multiple teaching awards, merit awards from the American Academy of Ophthalmology, American Society of Retinal Specialists, and was appointed the PI for 25 individual or multicenter clinical trials of vitreoretinal therapies.
Education & Training
Louisiana State UniversityFellowship, Surgical Retina and Vitreous, 1986 - 1988
Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 1983 - 1986
NYU Grossman Long Island School of MedicineInternship, Internal Medicine, 1982 - 1983
Stony Brook University Health Sciences Center School of MedicineClass of 1982
Certifications & Licensure
FL State Medical License 2015 - 2020
NY State Medical License 1983 - 2018
MA State Medical License 2007 - 2016
VT State Medical License 2006 - 2016- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Achievement Award American Academy of Ophthalmology, 2015
- Senior Honor Award The American Society of Retina Specialists, 2005
- Merit Award The American Society of Retina Specialists, 2002
- Join now to see all
Clinical Trials
- Scotoma Reduction in AMD Patients Treated With Ranibizumab Start of enrollment: 2007 Mar 01
- Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) Start of enrollment: 2008 Jun 01
Publications & Presentations
PubMed
- 103 citationsAdverse events after intravitreal infliximab (Remicade).Monica Giganti, Paul M. Beer, Nicole Lemanski, Coby L. Hartman, Jerome P. Schartman
Retina. 2010-01-01 - 10 citationsInfliximab stability after reconstitution, dilution, and storage under refrigeration.Paul M. Beer, Susan J. Wong, Jerome P. Schartman, Karen E. Kulas, Coby L. Hartman
Retina. 2010-01-01 - 417 citationsIntraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injectionPaul M. Beer, Sophie J. Bakri, Ravinder J. Singh, Weiguo Liu, George B Peters
Ophthalmology. 2003-04-01
Press Mentions
Novel Accommodating IOL Achieves Unique Level of Accommodative ChangeFebruary 16th, 2018
Grant Support
- Development of a Lens Replacement Device that Provides Enhanced Visual AcuityNSF2014–2016
- In Vivo Measurement of Accommodative ForcesNSF2013–2014
- In Vivo Measurement of Accommodative ForcesNEI2012–2013
Professional Memberships
- Fellow
- Fellow
Other Languages
- Romanian
Industry Relationships
- Founder & CEO, Z Lens LLC
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
